Europe

EMA launches new version of EudraCT

Wednesday, October 16, 2013 10:15 AM

The European Medicines Agency (EMA) has launched a new version of the European Clinical Trials Database (EudraCT). This version, EudraCT V9, marks the initial step of a process through which summary clinical trial results will be made publicly available through the EU Clinical Trials Register (EU CTR).

More... »

WIRB Copernicus Group

Clinlogix acquires ikfe CRO for Eurpoean market expansion

Wednesday, October 16, 2013 09:38 AM

Global CRO Clinlogix has acquired ikfe CRO, a CRO headquartered in Mainz, Germany that serves the European market.

More... »


Greenphire appoints Alex Livingstone senior director of business development

Tuesday, October 15, 2013 09:29 AM

Greenphire, a provider of payment technologies for the clinical trials industry, has appointed Alex Livingstone senior director of business development in Europe. Livingstone brings more than 12 years of eClinical software, pharmaceutical and biotechnology industry experience to the company, in a move designed to help Greenphire extend its footprint in European markets.

More... »

Scottish drug approval process to become more transparent

Wednesday, October 9, 2013 11:50 AM

Scottish patients will benefit from an increased range of new medicines due to changes announced by Alex Neil, the Scottish health secretary.

More... »

Report: British pharmaceutical market to reach $31.7 billion by 2020

Monday, September 30, 2013 02:39 PM

A growing disease burden, universal coverage and good access to healthcare facilities are boosting the U.K. healthcare market, but increasing use of generics and government cost-cutting measures to reduce expenditure are restricting further growth, according to research and consulting firm GlobalData.

More... »

Eisai, Clinigen partner on patient access program in Germany

Monday, September 9, 2013 11:56 AM

Eisai EMEA, an R&D based pharmaceutical company, has established a named patient access program to ensure patients continue to receive an uninterrupted supply of the anti-epilepsy drug Fycompa (perampanel), following the temporary suspension of commercial distribution in Germany. The access program will be managed by Clinigen Global Access Programs (GAP), a U.K.-headquartered specialty global pharmaceutical company.

More... »

EMA now accepting Safe-BioPharma digital signatures on eSubmissions

Friday, September 6, 2013 02:53 PM

Beginning this month, SAFE-BioPharma digital signatures will be accepted by the European Medicines Agency (EMA).  

More... »

Arthritis Research U.K., MS Society to award $10 million in research grants

Friday, September 6, 2013 02:52 PM

Arthritis Research U.K. and the MS Societyare partnering three research councils in the second stage of a nationwide project, which will see $10 million made available to researchers in stem cell and tissue engineering research.

More... »

Focused Ultrasound Foundation to launch research initiative

Friday, September 6, 2013 02:45 PM

The Focused Ultrasound Foundation and Royal Philips have entered into a public-private collaboration with The Institute of Cancer Research (ICR), London, and The Royal Marsden NHS Foundation Trust. The partnership will create a focal point for ultrasound therapy research at ICR and The Royal Marsden in London under the international Focused Ultrasound Foundation Centers of Excellence Program.

More... »

Almac partners for cancer research in Northern Ireland

Friday, September 6, 2013 02:42 PM

Almac Discovery has announced a $20.2million partnership with the Center for Cancer Research and Cell Biology (CCRCB) at Queen’s University Belfast (QUB) to accelerate cancer-focused drug discovery in Northern Ireland.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

August 18

Ebola outbreak highlights need to improve biosafety, infrastructure to handle future health emergencies

More African American professional women open to participating in medical research

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs